background

Selection of current studies

  • Evaluation of TAVR & Optimal Heart Failure Therapy (OHFT) versus OHFT in HF patients

600 patients, USA, Europe & Canada
Services: protocol, statistics, monitoring EU, CEC adjudication, DSMB, safety reporting EU and ECG Core Lab 

  • First in Man: Biodegradable polymer Sirolimus‐eluting stent (Chinese)

132 patients, Europe
Full-service including Core Lab

  • Post-marketing VT ablation study

382 patients, Europe and US
Regulatory Submission, Site Monitoring & Management and Safety reporting Europe

  • Evaluation of NOAC in Patients after Successful Transcatheter Aortic Valve Implantation (TAVI)

1,500 patients, Europe & US
Full-service 

  • Bioresorbable scaffold

2,690 patients, Europe
Services: CEC adjudication and SYNTAX Score analysis

  • High Bleeding Risk patients

4,300 patients, Global
Services: CEC adjudication, DSMB, Safety Reporting and Site Management BENELUX

1,400 patients, Europe
Services: Full study including OCT sub-study

  • Transcatheter aortic valve implantation 

2,500 patients, global
Services: protocol, CEC adjudication and DSMB

  •  Hybride surgical ablation 

210 patients, Europe
Services: monitoring, regulatory submission, safety reporting, CEC adjudication and data management

  • Bioresorbable scaffold

501 patients, global
Services: core lab (OCT, IVUS, MSCT and QCA) and CEC adjudication

16,000 patients, global
Services: protocol, statistics, data management, monitoring, CEC adjudication, DSMB and Core Lab

  •  Safety & efficacy dose finding trial NOAC 

105 patients, Europe
Services: Monitoring, data management, CRF, CEC adjudication and DSMB

  •  Coronary Artery Disease - Cardiotonic Agent

3,000 patients, Global
Services: CEC adjudication

  • Heart failure: CRT-D

3,796 patients, Global
Services: Core Lab (ECHO, Angio & ECG)

  •  Left Atrial Appendage Occlusion 

700 patients, Europe
Services: CEC adjudication

  •  Transcatheter aortic valve implantation 

1,000 patients, global
Services: Core Lab (ECHO)

190 patients, Europe
Services: protocol, statistics, data management, monitoring, CEC adjudication, DSMB and Core Lab

450 patients, Europe
Services: protocol, statistics, data management, monitoring, CEC adjudication, DSMB and Core Lab